Genesco Inc. Reports Fiscal 2027 First Quarter Results
Key Terms
non-gaap financial
gaap financial
basis points financial
international emergency economic powers act regulatory
--Sales and Bottom Line Improvement Exceed Expectations--
-- Journeys Comparable Sales +
--Seventh Consecutive Quarter of Positive Total Comparable Sales Growth--
--Announces New
--Raises Full Year EPS Outlook Range to
First Quarter Fiscal 2027 Financial Summary
-
Net sales of
increased$487 million 3% compared to Q1FY26 -
Comparable sales increased
2% , with stores up3% while e-commerce was flat - Gross margin improved 30 basis points compared to last year
- Selling and administrative expenses leveraged 30 basis points compared to last year; Adjusted selling and administrative expenses leveraged 60 basis points compared to last year
-
GAAP EPS was (
) and Non-GAAP EPS was ($1.42 )1 versus GAAP EPS of ($2.18 ) and Non-GAAP EPS of ($2.02 ) last year2$2.05
Mimi E. Vaughn, Genesco’s Board Chair, President, Chief Executive Officer and Interim Chief Financial Officer, said, “After a strong finish to Fiscal 2026, we are pleased to report a solid start to Fiscal 2027, delivering our seventh consecutive quarter of positive comparable sales and first quarter results that exceeded expectations across the board. The execution of our strategic initiatives continues to translate into tangible results. Journeys’ comparable sales grew mid-single-digits on top of a high-single-digit gain last year, as our work around product elevation and customer experience continues to drive market share gains. At the same time, Johnston & Murphy’s comparable sales accelerated sharply, increasing high-single-digits, while Schuh’s comparable sales performance reflects our decision to pull back on promotions and prioritize a more full-price selling model.”
Vaughn continued, “With the better than expected start, we are raising our full-year adjusted EPS outlook to
1Non-GAAP earnings per share (“EPS”) is a non-GAAP measure. Non-GAAP EPS excludes (i) a gross margin gain for a reversal of an inventory write-down related to license exits in Genesco Brands Group, net of tax effect, in the first quarter of Fiscal 2027, and (ii) a gain related to payment card interchange fee litigation, partially offset by charges for store restructuring, costs associated with information technology transformation, severance and professional fees related to shareholder activities, net of tax effect, in the first quarter of Fiscal 2027 and a charge for severance, net of tax effect, in the first quarter of Fiscal 2026 (“the Excluded Items”). A reconciliation of loss and loss per share from continuing operations in accordance with |
2 The effective tax rate for the first quarter was |
First Quarter Review
Net sales for the first quarter of Fiscal 2027 increased
Comparable Sales |
||
|
|
|
Comparable Same Store and E-commerce Sales: |
1QFY27 |
1QFY26 |
Journeys Group |
|
|
Schuh Group |
(9)% |
|
Johnston & Murphy Group |
|
(2)% |
Total Genesco Comparable Sales |
|
|
Same Store Sales |
|
|
Comparable E-commerce Sales |
|
|
The overall sales increase of
Gross margin for the first quarter this year of
Selling and administrative expenses improved to
Genesco’s GAAP operating loss for the first quarter was
The effective tax rate for the first quarter was
GAAP loss from continuing operations was
Tariff Refunds
The Company is expecting refunds under the International Emergency Economic Powers Act of approximately
Cost Savings Program
In connection with its IT Transformation and programs to drive automation, operating efficiencies and spend optimization, the Company is announcing a new cost reduction program which is expected to generate cost savings of
Cash, Borrowings and Inventory
Cash as of May 2, 2026, was
Capital Expenditures and Store Activity
For the first quarter this year, capital expenditures were
Share Repurchases
The Company did not repurchase any shares during the first quarter of Fiscal 2027. The Company currently has
Fiscal 2027 Outlook
Vaughn concluded, “We have clear plans in place to drive continued improvement in Fiscal 2027. Our top-line guidance reflects another year of overall positive comparable sales growth, offset by store closures and license transitions in our branded footwear group. The projected increase in our bottom line is being driven by another year of increased profitability at Journeys and improvement at Johnston & Murphy. We also expect higher gross margins, primarily at Schuh, as we reduce the business’ dependency on promotions and focus on returning to a full price, full margin sales model.”
For Fiscal 2027, the Company:
-
Raises expectations for adjusted diluted earnings per share from continuing operations to a range of
to$2.00 2, with the middle of the range the most likely outcome, as a result of the better than expected start to Fiscal 2027, versus the previous range of$2.40 to$1.90 per share$2.30 -
Continues to expect positive comparable sales of
1% to2% -
Continues to expect total sales to be down
1% to flat compared to Fiscal 2026, reflecting the impact of store closures and license exits, and -
Guidance assumes no further share repurchases and a tax rate of
30% for Fiscal 2027 but due to the valuation allowance, the tax rate for the second and third quarters of the year will be in the range of approximately7% to8%
| ____________________ |
2A reconciliation of the adjusted financial measures cited in the guidance to their corresponding measures as reported pursuant to GAAP is included in Schedule B to this press release. |
Conference Call, Management Commentary and Investor Presentation
The Company has posted detailed financial commentary and a supplemental financial presentation of first quarter results on its website, www.genesco.com, in the investor relations section. The Company's live conference call on May 29, 2026, at 7:30 a.m. (Central time), may be accessed through the Company's website, www.genesco.com. To listen live, please go to the website at least 15 minutes early to register, download and install any necessary software.
Safe Harbor Statement
This release contains forward-looking statements, including those regarding future sales, earnings, operating income, gross margins, expenses, tariff refunds, capital expenditures, depreciation and amortization, tax rates, store openings and closures, cost reductions, and all other statements not addressing solely historical facts or present conditions. Forward-looking statements are usually identified by or are associated with such words as “intend,” “expect,” “feel,” “should,” “believe,” “anticipate,” “optimistic,” “confident” and similar terminology. Actual results could vary materially from the expectations reflected in these statements. A number of factors could cause differences. These include adjustments to projections reflected in forward-looking statements, including those resulting from weakness in store, e-commerce and shopping mall traffic, the imposition of tariffs (including the timing and amount thereof) on products imported by the Company or its vendors as well as the ability and costs to move production of products in response to tariffs; the amount and timing of any tariff refunds; our ability to pass on price increases to our customers; restrictions on operations imposed by government entities and/or landlords, changes in public safety and health requirements, and limitations on the Company’s ability to adequately staff and operate stores. Differences from expectations could also result from store closures and effects on the business as a result of the level of consumer spending on our merchandise and interest in our brands and in general; the level and timing of promotional activity necessary to maintain inventories at appropriate levels; the Company’s ability to obtain from suppliers products that are in-demand on a timely basis and effectively manage disruptions in product supply or distribution, including disruptions as a result of pandemics or geopolitical events, including shipping disruptions near crucial trade routes; unfavorable trends in fuel costs, foreign exchange rates, foreign labor and material costs, and other factors affecting the cost of products; a disruption in shipping or increase in cost of our imported products, and other factors affecting the cost of products; our dependence on third-party vendors and licensors for the products we sell; store closures and effects on the business as a result of civil disturbances; our ability to renew our license agreements; impacts of the ongoing geopolitical conflicts around the world including, without limitation, the conflict with
About Genesco Inc.
Genesco Inc. (NYSE: GCO) is a footwear first company with distinctively positioned retail and lifestyle brands and proven omnichannel capabilities offering customers the footwear they desire in engaging shopping environments, including more than 1,200 retail stores and branded e-commerce websites. Its Journeys, Little Burgundy and Schuh brands serve teens, kids and young adults with on-trend fashion footwear that inspires youth culture in the
| GENESCO INC. | |||||||||||||
| Condensed Consolidated Statements of Operations | |||||||||||||
| (in thousands, except per share data) | |||||||||||||
| (Unaudited) | |||||||||||||
| Quarter 1 | Quarter 1 | ||||||||||||
| May 2, | % of | May 3, | % of | ||||||||||
2026 |
Net Sales | 2025 |
Net Sales | ||||||||||
| Net sales | $ |
487,025 |
|
100.0 |
% |
$ |
473,973 |
|
100.0 |
% |
|||
| Cost of sales |
|
258,106 |
|
53.0 |
% |
|
252,792 |
|
53.3 |
% |
|||
| Gross margin(1) |
|
228,919 |
|
47.0 |
% |
|
221,181 |
|
46.7 |
% |
|||
| Selling and administrative expenses(2) |
|
254,403 |
|
52.2 |
% |
|
249,035 |
|
52.5 |
% |
|||
| Asset impairments and other, net(3) |
|
(10,107 |
) |
-2.1 |
% |
|
291 |
|
0.1 |
% |
|||
| Operating loss |
|
(15,377 |
) |
-3.2 |
% |
|
(28,145 |
) |
-5.9 |
% |
|||
| Other components of net periodic benefit cost |
|
237 |
|
0.0 |
% |
|
180 |
|
0.0 |
% |
|||
| Interest expense, net |
|
265 |
|
0.1 |
% |
|
1,339 |
|
0.3 |
% |
|||
| Loss from continuing operations before | |||||||||||||
| income taxes |
|
(15,879 |
) |
-3.3 |
% |
|
(29,664 |
) |
-6.3 |
% |
|||
| Income tax benefit |
|
(1,073 |
) |
-0.2 |
% |
|
(8,452 |
) |
-1.8 |
% |
|||
| Loss from continuing operations |
|
(14,806 |
) |
-3.0 |
% |
|
(21,212 |
) |
-4.5 |
% |
|||
| Loss from discontinued operations, net of tax |
|
(8 |
) |
0.0 |
% |
|
(15 |
) |
0.0 |
% |
|||
| Net Loss | $ |
(14,814 |
) |
-3.0 |
% |
$ |
(21,227 |
) |
-4.5 |
% |
|||
| Basic loss per share: | |||||||||||||
| Before discontinued operations | $ |
(1.42 |
) |
$ |
(2.02 |
) |
|||||||
| Net loss | $ |
(1.42 |
) |
$ |
(2.02 |
) |
|||||||
| Diluted loss per share: | |||||||||||||
| Before discontinued operations | $ |
(1.42 |
) |
$ |
(2.02 |
) |
|||||||
| Net loss | $ |
(1.42 |
) |
$ |
(2.02 |
) |
|||||||
| Weighted-average shares outstanding: | |||||||||||||
| Basic |
|
10,428 |
|
|
10,495 |
|
|||||||
| Diluted |
|
10,428 |
|
|
10,495 |
|
|||||||
| (1) Includes a |
|||||||||||||
| (2) Includes a |
|||||||||||||
| (3) Includes a |
|||||||||||||
| GENESCO INC. | |||||||||||||
| Sales/Earnings Summary by Segment | |||||||||||||
| (in thousands) | |||||||||||||
| (Unaudited) | |||||||||||||
| Quarter 1 | Quarter 1 | ||||||||||||
| May 2, | % of | May 3, | % of | ||||||||||
2026 |
Net Sales | 2025 |
Net Sales | ||||||||||
| Sales: | |||||||||||||
| Journeys Group | $ |
285,323 |
|
58.6 |
% |
$ |
272,634 |
|
57.5 |
% |
|||
| Schuh Group |
|
90,702 |
|
18.6 |
% |
|
95,915 |
|
20.2 |
% |
|||
| Johnston & Murphy Group |
|
81,310 |
|
16.7 |
% |
|
76,839 |
|
16.2 |
% |
|||
| Genesco Brands Group |
|
29,690 |
|
6.1 |
% |
|
28,585 |
|
6.0 |
% |
|||
| Net Sales | $ |
487,025 |
|
100.0 |
% |
$ |
473,973 |
|
100.0 |
% |
|||
| Operating income (loss): | |||||||||||||
| Journeys Group | $ |
(11,555 |
) |
-4.0 |
% |
$ |
(15,283 |
) |
-5.6 |
% |
|||
| Schuh Group(1) |
|
(6,987 |
) |
-7.7 |
% |
|
(6,131 |
) |
-6.4 |
% |
|||
| Johnston & Murphy Group |
|
1,507 |
|
1.9 |
% |
|
500 |
|
0.7 |
% |
|||
| Genesco Brands Group(2) |
|
1,162 |
|
3.9 |
% |
|
698 |
|
2.4 |
% |
|||
| Corporate and Other(3) |
|
496 |
|
0.1 |
% |
|
(7,929 |
) |
-1.7 |
% |
|||
| Operating loss |
|
(15,377 |
) |
-3.2 |
% |
|
(28,145 |
) |
-5.9 |
% |
|||
| Other components of net periodic benefit cost |
|
237 |
|
0.0 |
% |
|
180 |
|
0.0 |
% |
|||
| Interest expense, net |
|
265 |
|
0.1 |
% |
|
1,339 |
|
0.3 |
% |
|||
| Loss from continuing operations before | |||||||||||||
| income taxes |
|
(15,879 |
) |
-3.3 |
% |
|
(29,664 |
) |
-6.3 |
% |
|||
| Income tax benefit |
|
(1,073 |
) |
-0.2 |
% |
|
(8,452 |
) |
-1.8 |
% |
|||
| Loss from continuing operations |
|
(14,806 |
) |
-3.0 |
% |
|
(21,212 |
) |
-4.5 |
% |
|||
| Loss from discontinued operations, net of tax |
|
(8 |
) |
0.0 |
% |
|
(15 |
) |
0.0 |
% |
|||
| Net Loss | $ |
(14,814 |
) |
-3.0 |
% |
$ |
(21,227 |
) |
-4.5 |
% |
|||
| (1) Includes a |
|||||||||||||
| (2) Includes a |
|||||||||||||
| (3) Includes a |
|||||||||||||
| GENESCO INC. | ||||||||
| Condensed Consolidated Balance Sheets | ||||||||
| (in thousands) | ||||||||
| (Unaudited) | ||||||||
| May 2, 2026 | May 3, 2025 | |||||||
| Assets | ||||||||
| Cash | $ |
27,122 |
$ |
21,748 |
||||
| Accounts receivable |
|
47,694 |
|
52,815 |
||||
| Inventories |
|
476,853 |
|
450,829 |
||||
| Other current assets(1) |
|
44,109 |
|
107,922 |
||||
| Total current assets |
|
595,778 |
|
633,314 |
||||
| Property and equipment |
|
239,701 |
|
236,909 |
||||
| Operating lease right of use assets |
|
485,669 |
|
472,091 |
||||
| Goodwill and other intangibles |
|
37,011 |
|
36,857 |
||||
| Other non-current assets |
|
25,870 |
|
25,420 |
||||
| Total Assets | $ |
1,384,029 |
$ |
1,404,591 |
||||
| Liabilities and Equity | ||||||||
| Accounts payable | $ |
129,033 |
$ |
122,166 |
||||
| Current portion long-term debt |
|
- |
|
7,299 |
||||
| Current portion operating lease liabilities |
|
115,773 |
|
126,954 |
||||
| Other current liabilities |
|
80,054 |
|
74,504 |
||||
| Total current liabilities |
|
324,860 |
|
330,923 |
||||
| Long-term debt |
|
45,346 |
|
113,733 |
||||
| Long-term operating lease liabilities |
|
414,604 |
|
389,384 |
||||
| Other long-term liabilities |
|
46,782 |
|
48,319 |
||||
| Equity |
|
552,437 |
|
522,232 |
||||
| Total Liabilities and Equity | $ |
1,384,029 |
$ |
1,404,591 |
||||
| (1) Includes prepaid income taxes of |
||||||||
| GENESCO INC. | ||||||||||||
| Store Count Activity | ||||||||||||
| Balance | Balance | Balance | ||||||||||
| 02/01/25 | Open | Close | 01/31/26 | Open | Close | 05/02/26 | ||||||
| Journeys Group | 1,006 |
8 |
49 |
965 |
0 |
25 |
940 |
|||||
| Schuh Group | 124 |
1 |
7 |
118 |
1 |
5 |
114 |
|||||
| Johnston & Murphy Group | 148 |
14 |
9 |
153 |
1 |
0 |
154 |
|||||
| Total Retail Stores | 1,278 |
23 |
65 |
1,236 |
2 |
30 |
1,208 |
|||||
| GENESCO INC. | |||||
| Comparable Sales | |||||
| Quarter 1 | |||||
| May 2, | May 3, | ||||
2026 |
2025 |
||||
| Journeys Group |
|
|
|||
| Schuh Group |
- |
|
|||
| Johnston & Murphy Group |
|
- |
|||
| Total Comparable Sales |
|
|
|||
| Same Store Sales |
|
|
|||
| Comparable E-commerce Sales |
|
|
|||
| Schedule B | |||||||||||||||||||
| Genesco Inc. | |||||||||||||||||||
| Adjustments to Reported Loss from Continuing Operations | |||||||||||||||||||
| Three Months Ended May 2, 2026 and May 3, 2025 | |||||||||||||||||||
| The Company believes that disclosure of earnings (loss) and earnings (loss) per share from continuing operations and operating income (loss) adjusted for the items not reflected in the previously announced expectations will be meaningful to investors, especially in light of the impact of such items on the results. | |||||||||||||||||||
| Quarter 1 | Quarter 1 | ||||||||||||||||||
| May 2, 2026 | May 3, 2025 | ||||||||||||||||||
| Net of | Per Share | Net of | Per Share | ||||||||||||||||
| In Thousands (except per share amounts) | Pretax | Tax | Amounts | Pretax | Tax | Amounts | |||||||||||||
| Loss from continuing operations, as reported | $ |
(14,806 |
) |
( |
$ |
(21,212 |
) |
($ |
2.02 |
) |
|||||||||
| Gross margin adjustment: | |||||||||||||||||||
| Reversal of inventory write-down related to exit of licenses | $ |
(84 |
) |
|
(78 |
) |
|
(0.01 |
) |
$ |
- |
|
- |
|
|
0.00 |
|
||
| Selling and administrative expense adjustment: | |||||||||||||||||||
| Costs associated with information technology transformation | $ |
1,698 |
|
|
1,578 |
|
|
0.15 |
|
$ |
- |
|
- |
|
|
0.00 |
|
||
| Asset impairments and other adjustments: | |||||||||||||||||||
| Asset impairment charges | $ |
- |
|
|
- |
|
|
0.00 |
|
$ |
34 |
|
24 |
|
|
0.00 |
|
||
| Severance |
|
90 |
|
|
84 |
|
|
0.01 |
|
|
257 |
|
185 |
|
|
0.02 |
|
||
| Costs associated with information technology transformation |
|
198 |
|
|
184 |
|
|
0.02 |
|
|
- |
|
- |
|
|
0.00 |
|
||
| Gain related to payment card interchange fee litigation |
|
(13,425 |
) |
|
(12,474 |
) |
|
(1.20 |
) |
|
- |
|
- |
|
|
0.00 |
|
||
| Store restructuring charges |
|
2,970 |
|
|
2,768 |
|
|
0.27 |
|
|
- |
|
- |
|
|
0.00 |
|
||
| Professional fees related to shareholder activities |
|
60 |
|
|
56 |
|
|
0.00 |
|
|
- |
|
- |
|
|
0.00 |
|
||
| Total asset impairments and other adjustments | $ |
(10,107 |
) |
|
(9,382 |
) |
|
(0.90 |
) |
$ |
291 |
|
209 |
|
|
0.02 |
|
||
| Income tax expense adjustments: | |||||||||||||||||||
| Tax impact share based awards |
|
- |
|
|
0.00 |
|
|
139 |
|
|
0.01 |
|
|||||||
| Other tax items |
|
(7 |
) |
|
0.00 |
|
|
(666 |
) |
|
(0.06 |
) |
|||||||
| Total income tax expense adjustments |
|
(7 |
) |
|
0.00 |
|
|
(527 |
) |
|
(0.05 |
) |
|||||||
| Adjusted loss from continuing operations (1) and (2) | $ |
(22,695 |
) |
($ |
2.18 |
) |
$ |
(21,530 |
) |
($ |
2.05 |
) |
|||||||
| (1) The adjusted tax rate for the first quarter of Fiscal 2027 and 2026 is |
|||||||||||||||||||
| (2) EPS reflects 10.4 million and 10.5 million share count for the first quarter of Fiscal 2027 and 2026, respectively, which excludes common stock equivalents in both periods due to the loss from continuing operations. | |||||||||||||||||||
| Genesco Inc. | ||||||||||
| Adjustments to Reported Operating Income (Loss), Gross Margin and Selling and Administrative Expenses | ||||||||||
| Three Months Ended May 2, 2026 and May 3, 2025 | ||||||||||
| Quarter 1 - May 2, 2026 | ||||||||||
| Operating | Asset Impair | Adj Operating | ||||||||
| In Thousands | Income (Loss) | & Other Adj | Income (Loss) | |||||||
| Journeys Group | $ |
(11,555 |
) |
$ |
- |
|
$ |
(11,555 |
) |
|
| Schuh Group |
|
(6,987 |
) |
|
289 |
|
|
(6,698 |
) |
|
| Johnston & Murphy Group |
|
1,507 |
|
|
- |
|
|
1,507 |
|
|
| Genesco Brands Group |
|
1,162 |
|
|
(84 |
) |
|
1,078 |
|
|
| Corporate and Other |
|
496 |
|
|
(8,698 |
) |
|
(8,202 |
) |
|
| Total Operating Loss | $ |
(15,377 |
) |
$ |
(8,493 |
) |
$ |
(23,870 |
) |
|
| % of sales |
|
-3.2 |
% |
|
-4.9 |
% |
||||
| Depreciation and amortization |
|
13,247 |
|
|||||||
| Adjusted loss before interest, taxes, depreciation and amortization ("EBITDA")(1) | $ |
(10,623 |
) |
|||||||
| % of sales |
|
-2.2 |
% |
|||||||
| Quarter 1 - May 3, 2025 | ||||||||||
| Operating | Asset Impair | Adj Operating | ||||||||
| In Thousands | Income (Loss) | & Other Adj | Income (Loss) | |||||||
| Journeys Group | $ |
(15,283 |
) |
$ |
- |
|
$ |
(15,283 |
) |
|
| Schuh Group |
|
(6,131 |
) |
|
- |
|
|
(6,131 |
) |
|
| Johnston & Murphy Group |
|
500 |
|
|
- |
|
|
500 |
|
|
| Genesco Brands Group |
|
698 |
|
|
- |
|
|
698 |
|
|
| Corporate and Other |
|
(7,929 |
) |
|
291 |
|
|
(7,638 |
) |
|
| Total Operating Loss | $ |
(28,145 |
) |
$ |
291 |
|
$ |
(27,854 |
) |
|
| % of sales |
|
-5.9 |
% |
|
-5.9 |
% |
||||
| Depreciation and amortization |
|
13,393 |
|
|||||||
| Adjusted loss before interest, taxes, depreciation and amortization ("EBITDA")(1) | $ |
(14,461 |
) |
|||||||
| % of sales |
|
-3.1 |
% |
|||||||
| (1) Excludes "Other components of net periodic benefit cost" line item on the Consolidated Statements of Operations. | ||||||||||
| Quarter 1 | |||||||
| In Thousands | May 2, 2026 | May 3, 2025 | |||||
| Gross margin, as reported | $ |
228,919 |
|
$ |
221,181 |
||
| % of sales |
|
47.0 |
% |
|
46.7 |
% |
|
| Reversal of inventory write-down related to exit of licenses |
|
(84 |
) |
|
- |
||
| Total adjustments |
|
(84 |
) |
|
- |
|
|
| Adjusted gross margin | $ |
228,835 |
|
$ |
221,181 |
||
| % of sales |
|
47.0 |
% |
|
46.7 |
% |
|
| Quarter 1 | |||||||
| In Thousands | May 2, 2026 | May 3, 2025 | |||||
| Selling and administrative expenses, as reported | $ |
254,403 |
|
$ |
249,035 |
||
| % of sales |
|
52.2 |
% |
|
52.5 |
% |
|
| Costs associated with information technology transformation |
|
(1,698 |
) |
|
- |
||
| Total adjustments |
|
(1,698 |
) |
|
- |
|
|
| Adjusted selling and administrative expenses | $ |
252,705 |
|
$ |
249,035 |
||
| % of sales |
|
51.9 |
% |
|
52.5 |
% |
|
| Schedule B | |||||||||||||
| Genesco Inc. | |||||||||||||
| Adjustments to Forecasted Earnings from Continuing Operations | |||||||||||||
| Fiscal Year Ending January 30, 2027 | |||||||||||||
| In millions (except per share amounts) | High Guidance | Low Guidance | |||||||||||
| Fiscal 2027 | Fiscal 2027 | ||||||||||||
| Net of Tax | Per Share | Net of Tax | Per Share | ||||||||||
| Forecasted earnings from continuing operations | $ |
29.8 |
|
$ |
2.75 |
|
$ |
25.1 |
|
$ |
2.32 |
|
|
| Asset impairments and other adjustments: | |||||||||||||
| Asset impairments and other matters |
|
5.6 |
|
|
0.52 |
|
|
6.0 |
|
|
0.55 |
|
|
| Gain related to payment card interchange fee litigation |
|
(9.4 |
) |
|
(0.87 |
) |
|
(9.4 |
) |
|
(0.87 |
) |
|
| Total asset impairments and other adjustments (1) |
|
(3.8 |
) |
|
(0.35 |
) |
|
(3.4 |
) |
|
(0.32 |
) |
|
| Adjusted forecasted earnings from continuing operations (2) | $ |
26.0 |
|
$ |
2.40 |
|
$ |
21.7 |
|
$ |
2.00 |
|
|
| (1) All adjustments are net of tax where applicable. The forecasted tax rate for Fiscal 2027 is approximately |
|||||||||||||
| (2) EPS reflects 10.9 million share count for Fiscal 2027 which includes common stock equivalents. | |||||||||||||
| This reconciliation reflects estimates and current expectations of future results. Actual results may vary materially from these expectations and estimates, for reasons including those included in the discussion of forward-looking statements elsewhere in this release. The Company disclaims any obligation to update such expectations and estimates. | |||||||||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20260528159479/en/
Genesco Financial Contact
Darryl MacQuarrie, Senior Director, FP&A & Investor Relations
(615) 308-5629 / dmacquarrie@genesco.com
Genesco Media Contact
Claire S. McCall, Director, Corporate Relations
(615) 308-2483 / cmccall@genesco.com
Source: Genesco Inc.